Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00468481 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety Study for an Oral Contraceptive Containing Folate
A Phase 3 study, sponsored by Bayer.
- Completed
- Registry status
- Phase 3
- Development phase
- 385
- Enrollment target
NCT00468481 is a Phase 3 study that has completed, run by Bayer. The registered enrollment target is 385 participants.
The verdict
NCT00468481, a Phase 3 study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 385 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether the study drug is safe and effective
Interventions
- DRUG Drospirenone/Ethinylestradiol/Methyltetrahydrofolate
- DRUG Drospirenone/Ethinylestradiol (Yaz)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 385 participants |
| Start Date | 2007-04 |
| Est. Completion | 2008-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00468481
The ClinicalTrials.gov registry entry for NCT00468481 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 385 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Drospirenone/Ethinylestradiol/Methyltetrahydrofolate is the first listed.
NCT00468481 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00468481 about?
NCT00468481 is a clinical study titled "Efficacy and Safety Study for an Oral Contraceptive Containing Folate". The purpose of this study is to determine whether the study drug is safe and effective
What is the current status of trial NCT00468481?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 385 participants. The study started on 2007-04. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00468481?
The interventions under investigation include: Drospirenone/Ethinylestradiol/Methyltetrahydrofolate (DRUG), Drospirenone/Ethinylestradiol (Yaz) (DRUG).
Who is sponsoring clinical trial NCT00468481?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.